Lisdexamfetamine Dimesylate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 10 USDMF, 2 EU WC, 10 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

239 FDF Dossiers, 133 FDA Orange Book, 58 Europe, 32 Canada, 6 Australia, 3 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 10MG, CAPSULE;ORAL - 20MG, CAPSULE;ORAL - 30MG, CAPSULE;ORAL - 40MG, CAPSULE;ORAL - 50MG, CAPSULE;ORAL - 60MG, CAPSULE;ORAL - 70MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 13 SPI Pharma, 8 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 8 Gangwal Healthcare, 1 Pfanstiehl, 4 ACG Worldwide, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 Bioplus Life Sciences, 3 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 5 Kerry, 3 Lonza Capsugel, 9 Microlex e.U, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 13 Roquette, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Fillers, Diluents & Binders, 22 Direct Compression, 16 Thickeners and Stabilizers, 14 Disintegrants & Superdisintegrants, 13 Taste Masking, 12 Co-Processed Excipients, 11 Lubricants & Glidants, 11 Chewable & Orodispersible Aids, 10 Granulation, 8 Empty Capsules, 7 Coating Systems & Additives, 4 Controlled & Modified Release, 4 Parenteral, 3 Coloring Agents, 3 Emulsifying Agents, 3 Film Formers & Plasticizers, 2 API Stability Enhancers, 2 Rheology Modifiers